Hyloris Pharmaceuticals Aktie

Kaufen

Verkaufen

5,78 EUR -0,06 EUR -1,03 %

17:04:14

STU

6,00 EUR -0,38 EUR -5,96 %

13.03.2026

EBR

Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Marktkap.168,00 Mio. EUR

Div. Rendite0,00%

WKNA2P7Y0

ISINBE0974363955

Hyloris Pharmaceuticals Aktien News

Sortieren:Datum Meistgelesen

14.03.24GlobeNewswireHyloris Reports Full Year Results for 2023 & Provides Business Outlook

14.03.24GlobeNewswireCommunication at the request of the FSMA on the transactions with Qliniq

08.03.24GlobeNewswireHyloris to Report 2023 Full-Year Results on 14 March 2024

27.02.24GlobeNewswireHyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

14.02.24GlobeNewswireHyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures

30.01.24GlobeNewswireHyloris and Purna Female Healthcare Announce Positive Results from Phase 2 Trial in Patients with Acute Vulvovaginal Candidiasis (VVC)

18.01.24GlobeNewswireHyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS)

16.01.24GlobeNewswireOrphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)

26.12.23GlobeNewswireHyloris Announces Positive Clinical Study Results for Valacyclovir Oral Suspension (HY-029)

21.12.23GlobeNewswireHyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome

04.12.23GlobeNewswireHyloris announces US FDA approval for Podofilox Gel

24.10.23GlobeNewswireHyloris Announces Out-Licensing of Atomoxetine Oral Liquid in Canada

18.10.23GlobeNewswireHyloris announces U.S. FDA Approval of Maxigesic® IV

06.09.23GlobeNewswireHyloris Pharmaceuticals Reports 2023 Half-Year Results and provides Business Outlook

22.06.23GlobeNewswireHyloris announces enrolment of first patient in a 4-arm clinical trial of Alenura(TM)

13.06.23GlobeNewswireHyloris shareholders approve all resolutions at the Annual General Meeting

08.06.23GlobeNewswireHyloris has been granted EUR 1 million in non-dilutive funding from the Walloon Region

02.05.23GlobeNewswireHyloris announces potential registration date for Maxigesic® IV in the US

28.04.23GlobeNewswireHyloris releases Annual Report 2022, including ESG objectives

18.04.23GlobeNewswireHyloris announces submission of Maxigesic® IV packaging data requested by the US FDA

Hyloris Pharmaceuticals News

Hyloris Pharmaceuticals News: auf dieser Seite finden Sie alle Hyloris Pharmaceuticals News und Nachrichten zur Hyloris Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Hyloris Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Hyloris Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.